{"transactions":[{"id":713321,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":31611,"kind":"organization","name":"SCLX Stock Acquisition JV LLC","position":1,"cik":"0001994894","reported_name":"SCLX Stock Acquisition JV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2026-07-08T01:25:20.000Z","date":"2026-07-03","kind":"other","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 3, 2026, the Reporting Person entered into a letter agreement (the \"Letter Agreement\") with Quantum Scan Holdings, Inc. (\"Q Scan\") and the other party named therein, pursuant to which the Reporting Person transferred the shares reported herein to Q Scan in exchange for shares of common stock of Q Scan. The price at which the shares reported herein are being transferred to Q Scan will be based on the closing price of the shares of Scilex common stock on the Nasdaq Capital Market on the last trading day immediately prior to the transfer of such shares pursuant to the Letter Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 3, 2026, the Reporting Person entered into a letter agreement (the \"Letter Agreement\") with Quantum Scan Holdings, Inc. (\"Q Scan\") and the other party named therein, pursuant to which the Reporting Person transferred the shares reported herein to Q Scan in exchange for shares of common stock of Q Scan. The price at which the shares reported herein are being transferred to Q Scan will be based on the closing price of the shares of Scilex common stock on the Nasdaq Capital Market on the last trading day immediately prior to the transfer of such shares pursuant to the Letter Agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 1-for-35 reverse stock split effected April 15, 2025."}],"balance_after":958263,"source":{"system":"sec-edgar","filing":"0001193125-26-297858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312526297858/ownership.xml","form_type":"4"}},{"id":804249,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51896,"kind":"person","name":"Ma Stephen Hoi","position":1,"cik":"0001954364","reported_name":"Ma Stephen Hoi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO and Secretary"}}],"security":"Warrant (right to buy)","published_at":"2026-04-20T12:56:24.000Z","date":"2026-04-17","kind":"purchase","planned":false,"acquired":true,"shares":650000,"price":0.1538,"value":99970.0,"ownership":{"direct":true},"balance_after":650000,"derivative":{"exercise_price":1.2,"exercise_date":"2026-04-17","expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001193125-26-162857","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312526162857/ownership.xml","form_type":"4"}},{"id":804408,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chair, CEO and President"}}],"security":"Warrant (right to buy)","published_at":"2026-04-20T12:52:50.000Z","date":"2026-04-17","kind":"sale","planned":false,"acquired":false,"shares":650000,"price":0.1538,"value":99970.0,"ownership":{"direct":true},"balance_after":2600000,"derivative":{"exercise_price":1.2,"exercise_date":"2026-04-16","expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001193125-26-162846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000119312526162846/ownership.xml","form_type":"4"}},{"id":804407,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chair, CEO and President"}}],"security":"Warrant (right to buy)","published_at":"2026-04-20T12:52:50.000Z","date":"2026-04-16","kind":"purchase","planned":false,"acquired":true,"shares":3250000,"price":0.1538,"value":499850.0,"ownership":{"direct":true},"balance_after":3250000,"derivative":{"exercise_price":1.2,"exercise_date":"2026-04-16","expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":3250000},"source":{"system":"sec-edgar","filing":"0001193125-26-162846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000119312526162846/ownership.xml","form_type":"4"}},{"id":956951,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":7345,"kind":"organization","name":"Scilex Holding Co","position":1,"cik":"0001820190","reported_name":"Scilex Holding Co","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T01:24:02.000Z","date":"2025-12-30","kind":"sale","planned":false,"acquired":false,"shares":9657300,"price":0.5394,"value":5209147.62,"ownership":{"direct":true},"balance_after":244445260,"source":{"system":"sec-edgar","filing":"0001193125-25-337437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525337437/ownership.xml","form_type":"4"}},{"id":956950,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":7345,"kind":"organization","name":"Scilex Holding Co","position":1,"cik":"0001820190","reported_name":"Scilex Holding Co","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T01:24:02.000Z","date":"2025-12-29","kind":"sale","planned":false,"acquired":false,"shares":7310984,"price":0.6555,"value":4792350.012,"ownership":{"direct":true},"balance_after":254102560,"source":{"system":"sec-edgar","filing":"0001193125-25-337437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525337437/ownership.xml","form_type":"4"}},{"id":956949,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":7345,"kind":"organization","name":"Scilex Holding Co","position":1,"cik":"0001820190","reported_name":"Scilex Holding Co","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T01:24:02.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":3689016,"price":0.7509,"value":2770082.1144,"ownership":{"direct":true},"balance_after":261413544,"source":{"system":"sec-edgar","filing":"0001193125-25-337437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525337437/ownership.xml","form_type":"4"}},{"id":1020636,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51896,"kind":"person","name":"Ma Stephen Hoi","position":1,"cik":"0001954364","reported_name":"Ma Stephen Hoi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-10-09T12:45:23.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Notwithstanding the preceding sentence, the shares of Common Stock subject to the Option will not be exercisable until such date as the Issuer's outstanding indebtedness under the Senior Secured Promissory Note issued by the Issuer to Oramed Pharmaceuticals, Inc. on September 21, 2023 and the Tranche B Senior Secured Convertible Notes issued by the Issuer to each of Oramed Pharmaceuticals, Inc., Nomis Bay Ltd., 3i LP and BPY Limited, has been repaid in full."}],"balance_after":60000,"derivative":{"exercise_price":17.58,"expiration_date":"2035-10-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193125-25-235245","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525235245/ownership.xml","form_type":"4"}},{"id":1020635,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74376,"kind":"person","name":"Chun Jay","position":1,"cik":"0001994406","reported_name":"Chun Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2025-10-09T12:43:50.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.58,"expiration_date":"2035-10-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-235243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525235243/ownership.xml","form_type":"4"}},{"id":1020776,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-10-09T12:42:24.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Notwithstanding the preceding sentence, the shares of Common Stock subject to the Option will not be exercisable until such date as the Issuer's outstanding indebtedness under the Senior Secured Promissory Note issued by the Issuer to Oramed Pharmaceuticals, Inc. on September 21, 2023 and the Tranche B Senior Secured Convertible Notes issued by the Issuer to each of Oramed Pharmaceuticals, Inc., Nomis Bay Ltd., 3i LP and BPY Limited, has been repaid in full."}],"balance_after":120000,"derivative":{"exercise_price":17.58,"expiration_date":"2035-10-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-25-235241","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000119312525235241/ownership.xml","form_type":"4"}},{"id":1020677,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2025-10-09T08:47:29.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.58,"expiration_date":"2035-10-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-235248","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000119312525235248/ownership.xml","form_type":"4"}},{"id":1020676,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74377,"kind":"person","name":"Followwill Dorman","position":1,"cik":"0001717947","reported_name":"Followwill Dorman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2025-10-09T08:40:18.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.58,"expiration_date":"2035-10-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-235239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717947/000119312525235239/ownership.xml","form_type":"4"}},{"id":1296116,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":31611,"kind":"organization","name":"SCLX Stock Acquisition JV LLC","position":1,"cik":"0001994894","reported_name":"SCLX Stock Acquisition JV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-01-24T00:49:49.000Z","date":"2025-01-21","kind":"other","planned":false,"acquired":false,"shares":3250000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transferred pursuant to the terms of an Amendment to Senior Secured Promissory Note (the \"Amendment Letter\") the Issuer and the Reporting Person entered into with Oramed Pharmaceuticals Inc. (\"Oramed\") for the extension of the maturity date of that certain senior secured promissory note previously issued by the Issuer to Oramed on September 21, 2023. Under the terms of the Amendment Letter and in consideration for such extension and to limit certain noteholders' rights to exercise certain secured creditor remedies (including recourse against the assets of the Reporting Person as a grantor under the Security Agreement (as defined in the Amendment Letter)), the Reporting Person transferred to Oramed an aggregate of 3,250,000 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transferred pursuant to the terms of an Amendment to Senior Secured Promissory Note (the \"Amendment Letter\") the Issuer and the Reporting Person entered into with Oramed Pharmaceuticals Inc. (\"Oramed\") for the extension of the maturity date of that certain senior secured promissory note previously issued by the Issuer to Oramed on September 21, 2023. Under the terms of the Amendment Letter and in consideration for such extension and to limit certain noteholders' rights to exercise certain secured creditor remedies (including recourse against the assets of the Reporting Person as a grantor under the Security Agreement (as defined in the Amendment Letter)), the Reporting Person transferred to Oramed an aggregate of 3,250,000 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person."}],"balance_after":51039214,"source":{"system":"sec-edgar","filing":"0000950170-25-008463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017025008463/ownership.xml","form_type":"4"}},{"id":1299571,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":31611,"kind":"organization","name":"SCLX Stock Acquisition JV LLC","position":1,"cik":"0001994894","reported_name":"SCLX Stock Acquisition JV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-01-18T01:27:54.000Z","date":"2025-01-16","kind":"other","planned":false,"acquired":false,"shares":779371,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transferred in connection with a First Amendment to License and Commercialization Agreement (the \"License Amendment\") the Issuer entered into with Rxomeg Therapeutics, LLC a/k/a Romeg Therapeutics, LLC (\"Romeg\"), as contemplated by that certain Transfer Agreement entered into between the Issuer and Romeg (the \"Transfer Agreement\"). In consideration of the execution of the License Amendment and the Transfer Agreement, the Reporting Person transferred to Romeg an aggregate of 779,371 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transferred in connection with a First Amendment to License and Commercialization Agreement (the \"License Amendment\") the Issuer entered into with Rxomeg Therapeutics, LLC a/k/a Romeg Therapeutics, LLC (\"Romeg\"), as contemplated by that certain Transfer Agreement entered into between the Issuer and Romeg (the \"Transfer Agreement\"). In consideration of the execution of the License Amendment and the Transfer Agreement, the Reporting Person transferred to Romeg an aggregate of 779,371 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person."}],"balance_after":54289214,"source":{"system":"sec-edgar","filing":"0000950170-25-006876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017025006876/ownership.xml","form_type":"4"}},{"id":1309520,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":31611,"kind":"organization","name":"SCLX Stock Acquisition JV LLC","position":1,"cik":"0001994894","reported_name":"SCLX Stock Acquisition JV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T00:12:44.000Z","date":"2025-01-02","kind":"other","planned":false,"acquired":false,"shares":5000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transferred pursuant to the terms of a Deferral and Consent Letter (collectively, the \"Consent Letters\") the Issuer and the Reporting Person entered into with each of (i) Nomis Bay Ltd and BPY Limited, (ii) Oramed Pharmaceuticals Inc. (\"Oramed\") and (iii) 3i, LP, respectively (collectively, the \"Noteholders\") for the deferral of certain amortization payments owned by the Issuer to the Noteholders. Under the terms of the Consent Letters and in consideration for such deferrals and to limit the Noteholders' right to exercise certain secured creditor remedies (including recourse against the assets of the Reporting Person as a grantor under the Security Agreement (as defined in the Consent Letters)),"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) the Reporting Person transferred to the Noteholders an aggregate of 5,000,000 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person, of which 2,500,000 shares were delivered to Oramed, 720,000 shares were delivered to BPY Limited, 1,280,000 shares were delivered to Nomis Bay Ltd, and 500,000 shares were delivered to 3i, LP."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transferred pursuant to the terms of a Deferral and Consent Letter (collectively, the \"Consent Letters\") the Issuer and the Reporting Person entered into with each of (i) Nomis Bay Ltd and BPY Limited, (ii) Oramed Pharmaceuticals Inc. (\"Oramed\") and (iii) 3i, LP, respectively (collectively, the \"Noteholders\") for the deferral of certain amortization payments owned by the Issuer to the Noteholders. Under the terms of the Consent Letters and in consideration for such deferrals and to limit the Noteholders' right to exercise certain secured creditor remedies (including recourse against the assets of the Reporting Person as a grantor under the Security Agreement (as defined in the Consent Letters)),"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from footnote 1) the Reporting Person transferred to the Noteholders an aggregate of 5,000,000 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person, of which 2,500,000 shares were delivered to Oramed, 720,000 shares were delivered to BPY Limited, 1,280,000 shares were delivered to Nomis Bay Ltd, and 500,000 shares were delivered to 3i, LP."}],"balance_after":55068585,"source":{"system":"sec-edgar","filing":"0000950170-25-002437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017025002437/ownership.xml","form_type":"4"}},{"id":1326466,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-12-18T19:04:41.000Z","date":"2024-12-18","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.46,"value":13800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the Reporting Person of 30,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions over a range of sales prices."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on December 18, 2024 at prices ranging from $0.4590 to $0.4600 per share, inclusive. The amount reflected has been rounded to four decimal points. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range."}],"balance_after":139333,"source":{"system":"sec-edgar","filing":"0000950170-24-138066","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024138066/ownership.xml","form_type":"4"}},{"id":1327751,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74376,"kind":"person","name":"Chun Jay","position":1,"cik":"0001994406","reported_name":"Chun Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-12-17T22:16:48.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.5045,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-137382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024137382/ownership.xml","form_type":"4"}},{"id":1327878,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74377,"kind":"person","name":"Followwill Dorman","position":1,"cik":"0001717947","reported_name":"Followwill Dorman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-12-17T17:15:00.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.5045,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-137377","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717947/000095017024137377/ownership.xml","form_type":"4"}},{"id":1327912,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-12-17T17:13:03.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.5045,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-137369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017024137369/ownership.xml","form_type":"4"}},{"id":1378797,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2024-10-31T16:44:57.000Z","date":"2024-10-31","kind":"purchase","planned":false,"acquired":true,"shares":8888,"price":0.9396,"value":8351.1648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 8,888 shares of common stock, par value $0.0001 per share (the \"Common Stock\")."}],"balance_after":320161,"source":{"system":"sec-edgar","filing":"0000950170-24-119394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024119394/ownership.xml","form_type":"4"}},{"id":1379952,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-29T18:59:31.000Z","date":"2024-10-29","kind":"purchase","planned":false,"acquired":true,"shares":32000,"price":0.9897,"value":31670.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 32,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions at a price of $0.9897."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on October 29, 2024 at a price of $0.9897. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range."}],"balance_after":109333,"source":{"system":"sec-edgar","filing":"0000950170-24-118435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024118435/ownership.xml","form_type":"4"}},{"id":1383929,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74376,"kind":"person","name":"Chun Jay","position":1,"cik":"0001994406","reported_name":"Chun Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-18T20:29:19.000Z","date":"2024-10-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.95,"value":4750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 5,000 shares of common stock, par value $0.0001 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"Open market purchase by the reporting person of 5,000 shares of common stock, par value $0.0001 per share."}],"balance_after":112500,"source":{"system":"sec-edgar","filing":"0000950170-24-115629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024115629/ownership.xml","form_type":"4"}},{"id":1383947,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74377,"kind":"person","name":"Followwill Dorman","position":1,"cik":"0001717947","reported_name":"Followwill Dorman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-18T16:29:32.000Z","date":"2024-10-18","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.99,"value":990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 1,000 shares of common stock, par value $0.0001 per share."}],"balance_after":2300,"source":{"system":"sec-edgar","filing":"0000950170-24-115630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717947/000095017024115630/ownership.xml","form_type":"4"}},{"id":1384037,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2024-10-18T13:08:55.000Z","date":"2024-10-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.971,"value":9710.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\")."}],"balance_after":60070,"source":{"system":"sec-edgar","filing":"0000950170-24-115449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024115449/ownership.xml","form_type":"4"}},{"id":1383948,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-18T09:14:55.000Z","date":"2024-10-17","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.9496,"value":18992.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 20,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions over a range of sales prices."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on October 17, 2024 at prices ranging from $0.9479 to $0.9497 per share, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000950170-24-115452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017024115452/ownership.xml","form_type":"4"}},{"id":1383931,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-18T09:10:30.000Z","date":"2024-10-17","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":0.9,"value":1800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 2,000 shares of common stock, par value $0.0001 per share."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000950170-24-115450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717972/000095017024115450/ownership.xml","form_type":"4"}},{"id":1384510,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51896,"kind":"person","name":"Ma Stephen Hoi","position":1,"cik":"0001954364","reported_name":"Ma Stephen Hoi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-17T15:09:25.000Z","date":"2024-10-16","kind":"purchase","planned":false,"acquired":true,"shares":6700,"price":0.97,"value":6499.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market purchase by the reporting person of 6,700 shares of common stock, par value $0.0001 per share."}],"balance_after":22840,"source":{"system":"sec-edgar","filing":"0000950170-24-115199","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024115199/ownership.xml","form_type":"4"}},{"id":1384647,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-17T12:44:02.000Z","date":"2024-10-16","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.9917,"value":29751.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 30,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions over a range of sales prices."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on October 16, 2024 at prices ranging from $0.9674 to $1.0000 per share, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range."}],"balance_after":77333,"source":{"system":"sec-edgar","filing":"0000950170-24-115226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024115226/ownership.xml","form_type":"4"}},{"id":1429709,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74936,"kind":"person","name":"Navani Annu","position":1,"cik":"0002033328","reported_name":"Navani Annu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-08-19T17:08:43.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":1.23,"expiration_date":"2034-08-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-24-098670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033328/000095017024098670/ownership.xml","form_type":"4"}},{"id":1468575,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74377,"kind":"person","name":"Followwill Dorman","position":1,"cik":"0001717947","reported_name":"Followwill Dorman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-26T21:31:14.000Z","date":"2024-06-26","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was March 15, 2024, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":99000,"derivative":{"exercise_price":1.37,"expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-24-078116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1717947/000095017024078116/ownership.xml","form_type":"4"}},{"id":1468574,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74377,"kind":"person","name":"Followwill Dorman","position":1,"cik":"0001717947","reported_name":"Followwill Dorman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-26T21:31:14.000Z","date":"2024-06-26","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":1.37,"value":1370.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/12th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was March 15, 2024, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0000950170-24-078116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717947/000095017024078116/ownership.xml","form_type":"4"}},{"id":1468572,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-26T21:29:00.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.37,"expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-078114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717972/000095017024078114/ownership.xml","form_type":"4"}},{"id":1468573,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74377,"kind":"person","name":"Followwill Dorman","position":1,"cik":"0001717947","reported_name":"Followwill Dorman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-26T21:27:51.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.37,"expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-078113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717947/000095017024078113/ownership.xml","form_type":"4"}},{"id":1472703,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51896,"kind":"person","name":"Ma Stephen Hoi","position":1,"cik":"0001954364","reported_name":"Ma Stephen Hoi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-20T20:54:31.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":148000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000950170-24-075674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024075674/ownership.xml","form_type":"4"}},{"id":1472702,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51896,"kind":"person","name":"Ma Stephen Hoi","position":1,"cik":"0001954364","reported_name":"Ma Stephen Hoi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-20T20:54:31.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":1.41,"value":2820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":16140,"source":{"system":"sec-edgar","filing":"0000950170-24-075674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024075674/ownership.xml","form_type":"4"}},{"id":1472701,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74376,"kind":"person","name":"Chun Jay","position":1,"cik":"0001994406","reported_name":"Chun Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-20T20:49:40.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":245000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-075669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024075669/ownership.xml","form_type":"4"}},{"id":1472700,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74376,"kind":"person","name":"Chun Jay","position":1,"cik":"0001994406","reported_name":"Chun Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:49:40.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":1.41,"value":7050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":107500,"source":{"system":"sec-edgar","filing":"0000950170-24-075669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024075669/ownership.xml","form_type":"4"}},{"id":1472736,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-20T18:07:26.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":245000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-075773","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017024075773/ownership.xml","form_type":"4"}},{"id":1472735,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T18:07:26.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":1.41,"value":7050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000950170-24-075773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017024075773/ownership.xml","form_type":"4"}},{"id":1472956,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-20T16:43:46.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the original number of shares subject to the option vested on March 18, 2020, and 1/36th of the remaining number of shares subject to the option vested and shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":7880598,"derivative":{"exercise_price":1.73,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000950170-24-075656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024075656/ownership.xml","form_type":"4"}},{"id":1472955,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-20T16:43:46.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":14000,"price":1.73,"value":24220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/4th of the original number of shares subject to the option vested on March 18, 2020, and 1/36th of the remaining number of shares subject to the option vested and shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":47333,"source":{"system":"sec-edgar","filing":"0000950170-24-075656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024075656/ownership.xml","form_type":"4"}},{"id":1475138,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-19T01:26:53.000Z","date":"2024-06-18","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":194000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000950170-24-075213","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024075213/ownership.xml","form_type":"4"}},{"id":1475137,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2024-06-19T01:26:53.000Z","date":"2024-06-18","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":1.41,"value":8460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":311273,"source":{"system":"sec-edgar","filing":"0000950170-24-075213","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024075213/ownership.xml","form_type":"4"}},{"id":1478767,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-14T16:02:58.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":166667,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000950170-24-073618","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024073618/ownership.xml","form_type":"4"}},{"id":1478766,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-14T16:02:58.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":33333,"price":1.41,"value":46999.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":33333,"source":{"system":"sec-edgar","filing":"0000950170-24-073618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024073618/ownership.xml","form_type":"4"}},{"id":1511236,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2024-05-17T22:42:21.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.8797,"value":43985.0,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market purchase by the reporting person of 50,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions over a range of sales prices."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 17, 2024 at prices ranging from $0.8700 to $0.8800 per share, inclusive. The amount reflected has been rounded to 4 decimal points."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range."}],"balance_after":50070,"source":{"system":"sec-edgar","filing":"0000950170-24-062009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017024062009/ownership.xml","form_type":"4"}},{"id":1510297,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74376,"kind":"person","name":"Chun Jay","position":1,"cik":"0001994406","reported_name":"Chun Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-17T22:41:24.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":57500,"price":0.8981,"value":51640.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market purchase by the reporting person of 57,500 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions over a range of sales prices."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 17, 2024 at prices ranging from $0.8978 to $0.8998 per share, inclusive. The amount reflected has been rounded to 4 decimal points."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range."}],"balance_after":102500,"source":{"system":"sec-edgar","filing":"0000950170-24-062008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024062008/ownership.xml","form_type":"4"}},{"id":1510298,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51896,"kind":"person","name":"Ma Stephen Hoi","position":1,"cik":"0001954364","reported_name":"Ma Stephen Hoi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-17T20:29:14.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":14140,"price":0.88,"value":12443.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market purchase by the reporting person of 14,140 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions at the same purchase price."}],"balance_after":14140,"source":{"system":"sec-edgar","filing":"0000950170-24-061690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024061690/ownership.xml","form_type":"4"}},{"id":1510965,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-17T17:36:39.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":56939,"price":0.915,"value":52099.185,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Open market purchase by the reporting person of 56,939 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held in a family trust of which the reporting person is a co-trustee with his spouse."}],"balance_after":155882,"source":{"system":"sec-edgar","filing":"0000950170-24-061928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024061928/ownership.xml","form_type":"4"}},{"id":1510964,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-17T17:36:39.000Z","date":"2024-05-16","kind":"purchase","planned":false,"acquired":true,"shares":83061,"price":0.8409,"value":69845.9949,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market purchase by the reporting person of 83,061 shares of common stock, par value $0.0001 per share (the \"Common Stock\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held in a family trust of which the reporting person is a co-trustee with his spouse."}],"balance_after":98943,"source":{"system":"sec-edgar","filing":"0000950170-24-061928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017024061928/ownership.xml","form_type":"4"}},{"id":1764319,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-10-06T01:35:29.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-23-052259","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000095017023052259/ownership.xml","form_type":"4"}},{"id":1764170,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74376,"kind":"person","name":"Chun Jay","position":1,"cik":"0001994406","reported_name":"Chun Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-10-06T01:26:09.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-23-052255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017023052255/ownership.xml","form_type":"4"}},{"id":1764169,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51896,"kind":"person","name":"Ma Stephen Hoi","position":1,"cik":"0001954364","reported_name":"Ma Stephen Hoi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-10-06T01:24:31.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-23-052254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017023052254/ownership.xml","form_type":"4"}},{"id":1764285,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-10-05T21:28:03.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-23-052257","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000095017023052257/ownership.xml","form_type":"4"}},{"id":1764190,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-10-05T21:26:38.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-23-052256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017023052256/ownership.xml","form_type":"4"}},{"id":1774282,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2023-09-25T16:27:57.000Z","date":"2023-09-21","kind":"sale","planned":false,"acquired":false,"shares":4490617,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Stock Purchase Agreement, dated September 21, 2023, between the Reporting Person and Scilex Holding Company (\"Scilex\"), Scilex purchased the following securities from the Reporting Person for an aggregate purchase price of (a) $10 million in cash; plus (b) the assumption by Scilex of $100 million of debt under the Reporting Person's non-amortizing super-priority senior secured debtor-in-possession term loan facility; plus (c) the assumption by Scilex of certain obligations of the Reporting Person for legal fees and expenses in the amount of approximately $12.25 million; plus (d) a credit bid of approximately $23 million owed to Scilex under the Reporting Person's non-amortizing super-priority junior secured term loan facility: (i) 60,068,585 shares of Common Stock of Scilex; (ii) 29,057,097 shares of Series A Preferred Stock of Scilex; and (iii) warrants exercisable for 4,490,617 shares of Common Stock of Scilex."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":4490617},"source":{"system":"sec-edgar","filing":"0001104659-23-103527","document":"tm2326753-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465923103527/tm2326753-1_4.xml","form_type":"4"}},{"id":1774281,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T16:27:57.000Z","date":"2023-09-21","kind":"sale","planned":false,"acquired":false,"shares":60068585,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Stock Purchase Agreement, dated September 21, 2023, between the Reporting Person and Scilex Holding Company (\"Scilex\"), Scilex purchased the following securities from the Reporting Person for an aggregate purchase price of (a) $10 million in cash; plus (b) the assumption by Scilex of $100 million of debt under the Reporting Person's non-amortizing super-priority senior secured debtor-in-possession term loan facility; plus (c) the assumption by Scilex of certain obligations of the Reporting Person for legal fees and expenses in the amount of approximately $12.25 million; plus (d) a credit bid of approximately $23 million owed to Scilex under the Reporting Person's non-amortizing super-priority junior secured term loan facility: (i) 60,068,585 shares of Common Stock of Scilex; (ii) 29,057,097 shares of Series A Preferred Stock of Scilex; and (iii) warrants exercisable for 4,490,617 shares of Common Stock of Scilex."}],"balance_after":1917210,"source":{"system":"sec-edgar","filing":"0001104659-23-103527","document":"tm2326753-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465923103527/tm2326753-1_4.xml","form_type":"4"}},{"id":1944406,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2023-03-20T21:19:03.000Z","date":"2023-03-17","kind":"other","planned":false,"acquired":true,"shares":2730,"price":8.6002,"value":23478.546,"ownership":{"direct":false,"nature":"By BioVintage, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 30, 2022, the Board of Directors of Sorrento Therapeutics, Inc. (\"Sorrento\") declared a stock dividend (the \"Dividend\") to all holders of record of its common stock as of the close of business on January 9, 2023, of 0.1410127 of a share of common stock, par value $0.0001 per share, of the Issuer (\"Scilex Common Stock\") for each one share of common stock, par value $0.0001 per share, of Sorrento (\"Sorrento Common Stock\"). The Reporting Person wrote a put option in Sorrento Common Stock on August 26, 2022 (the \"Put Option\"), which was adjusted as a result of the Stock Dividend to relate to an aggregate of 19,500 shares of Sorrento Common Stock and 2,730 shares of Scilex Common Stock and to reflect a corresponding change to the exercise price of the Put Option to $0.80268 per share of Sorrento Common Stock and $8.6002 per share of Scilex Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) The Put Option settled on March 17, 2023 and resulted in the Reporting Person acquiring 2,730 shares of Scilex Common Stock at a price of $8.6002 per share of Scilex Common Stock, in addition to 19,500 shares of Sorrento Common Stock at a price of $0.80268 per share of Sorrento Common Stock."}],"balance_after":2730,"source":{"system":"sec-edgar","filing":"0000899243-23-009127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000089924323009127/doc4.xml","form_type":"4"}},{"id":2049082,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-23T16:11:40.000Z","date":"2023-01-19","kind":"other","acquired":false,"shares":73740795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 19, 2023, the Reporting Person paid its previously announced stock dividend (the \"Dividend\") consisting of an aggregate of 75,999,853 shares of common stock of Scilex Holding Company held by the Reporting Person (the \"Dividend Shares\") to record holders of the Reporting Person's common stock and certain warrants to purchase the Reporting Person's common stock as of January 9, 2023 (the \"Record Date\").  An aggregate of 2,259,058 Dividend Shares are being held in abeyance by the Reporting Person for the benefit of certain holders of warrants to purchase shares of common stock of the Reporting Person who may be entitled to such shares pursuant to the terms of the applicable warrants following the exercise of such warrants, and at the time such shares are distributed to the applicable warrantholders, the Reporting Person will file a Form 4 reporting such distribution."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued form footnote 1) The Reporting Person distributed 0.1410127 of a share of the Issuer's common stock for each share of the Reporting Person's common stock outstanding as of the close of business on the Record Date. The stock ratio was calculated by dividing 76,000,000 by the number of shares of the Reporting Person's common stock and warrants to purchase shares of the Reporting Person's common stock outstanding on the Record Date. No fractional shares were issued in connection with the Dividend and the equityholders of the Reporting Person who were entitled to receive fractional shares of the Dividend Stock received cash (without interest) in lieu of such fractional shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"On January 19, 2023, the Reporting Person paid its previously announced stock dividend (the \"Dividend\") consisting of an aggregate of 75,999,853 shares of common stock of Scilex Holding Company held by the Reporting Person (the \"Dividend Shares\") to record holders of the Reporting Person's common stock and certain warrants to purchase the Reporting Person's common stock as of January 9, 2023 (the \"Record Date\").  An aggregate of 2,259,058 Dividend Shares are being held in abeyance by the Reporting Person for the benefit of certain holders of warrants to purchase shares of common stock of the Reporting Person who may be entitled to such shares pursuant to the terms of the applicable warrants following the exercise of such warrants, and at the time such shares are distributed to the applicable warrantholders, the Reporting Person will file a Form 4 reporting such distribution."},{"field":"shares","element":"transactionShares","label":"F2","text":"(Continued form footnote 1) The Reporting Person distributed 0.1410127 of a share of the Issuer's common stock for each share of the Reporting Person's common stock outstanding as of the close of business on the Record Date. The stock ratio was calculated by dividing 76,000,000 by the number of shares of the Reporting Person's common stock and warrants to purchase shares of the Reporting Person's common stock outstanding on the Record Date. No fractional shares were issued in connection with the Dividend and the equityholders of the Reporting Person who were entitled to receive fractional shares of the Dividend Stock received cash (without interest) in lieu of such fractional shares."}],"balance_after":61985795,"source":{"system":"sec-edgar","filing":"0000899243-23-002368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924323002368/doc4.xml","form_type":"4"}},{"id":2053599,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":29039,"kind":"person","name":"Thompson Tommy G","position":1,"cik":"0001324863","reported_name":"Thompson Tommy G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T22:35:01.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-23-001882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324863/000089924323001882/doc4.xml","form_type":"4"}},{"id":2053499,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":874,"kind":"person","name":"Hamill Laura","position":1,"cik":"0001751804","reported_name":"Hamill Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T22:30:35.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-23-001877","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751804/000089924323001877/doc4.xml","form_type":"4"}},{"id":2053634,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T22:25:53.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":350000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000899243-23-001870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263500/000089924323001870/doc4.xml","form_type":"4"}},{"id":2053710,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":51941,"kind":"person","name":"Ji Henry","position":1,"cik":"0001470981","reported_name":"Ji Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T22:21:09.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":9000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":9000000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":9000000},"source":{"system":"sec-edgar","filing":"0000899243-23-001866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1470981/000089924323001866/doc4.xml","form_type":"4"}},{"id":2053498,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74377,"kind":"person","name":"Followwill Dorman","position":1,"cik":"0001717947","reported_name":"Followwill Dorman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T17:36:56.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-23-001884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717947/000089924323001884/doc4.xml","form_type":"4"}},{"id":2053908,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":66911,"kind":"person","name":"Lee Tien-Li","position":1,"cik":"0001940120","reported_name":"Lee Tien-Li","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T17:31:54.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-23-001880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1940120/000089924323001880/doc4.xml","form_type":"4"}},{"id":2053497,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T17:28:24.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-23-001872","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717972/000089924323001872/doc4.xml","form_type":"4"}},{"id":2053624,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":75026,"kind":"person","name":"SHAH JAISIM","position":1,"cik":"0001242133","reported_name":"SHAH JAISIM","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T17:23:29.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":1700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":1700000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":1700000},"source":{"system":"sec-edgar","filing":"0000899243-23-001869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242133/000089924323001869/doc4.xml","form_type":"4"}},{"id":2099198,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2022-12-02T19:21:40.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":224841,"price":0.3507,"value":78851.7387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.32 to $0.36 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price."}],"balance_after":4490617,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":224841},"source":{"system":"sec-edgar","filing":"0000899243-22-037521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924322037521/doc4.xml","form_type":"4"}},{"id":2104654,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2022-11-25T15:21:39.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":46172,"price":0.4374,"value":20195.6328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.37 to $0.45 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price."}],"balance_after":4265776,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":46172},"source":{"system":"sec-edgar","filing":"0000899243-22-037015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924322037015/doc4.xml","form_type":"4"}},{"id":2105893,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2022-11-23T17:59:05.000Z","date":"2022-11-23","kind":"purchase","acquired":true,"shares":442829,"price":0.3967,"value":175670.2643,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2444 to $0.45 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price."}],"balance_after":4219604,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":442829},"source":{"system":"sec-edgar","filing":"0000899243-22-036956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924322036956/doc4.xml","form_type":"4"}},{"id":2107643,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2022-11-22T19:24:39.000Z","date":"2022-11-22","kind":"purchase","acquired":true,"shares":672775,"price":0.226,"value":152047.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.13 to $0.28 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price."}],"balance_after":3776775,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":672775},"source":{"system":"sec-edgar","filing":"0000899243-22-036807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924322036807/doc4.xml","form_type":"4"}},{"id":2115724,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":83028,"kind":"organization","name":"Vickers Venture Fund VI Pte Ltd","position":1,"cik":"0001839162","reported_name":"Vickers Venture Fund VI Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See footnote (1)"}},{"id":122360,"kind":"organization","name":"Vickers Venture Fund VI (Plan) Pte Ltd","position":2,"cik":"0001839160","reported_name":"Vickers Venture Fund VI (Plan) Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}},{"id":20713,"kind":"person","name":"Chi Jeffrey","position":3,"cik":"0001839163","reported_name":"Chi Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}},{"id":122361,"kind":"person","name":"Ho Chris","position":4,"cik":"0001838628","reported_name":"Ho Chris","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}}],"security":"Warrants","published_at":"2022-11-16T02:47:41.000Z","date":"2022-11-10","kind":"other","acquired":false,"shares":578160,"ownership":{"direct":false,"nature":"By Vickeres Venture Fund VI (Plan) Pte Ltd"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I"},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company (\"New Scilex Warrants\") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. (\"Sorrento\") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i)\nVickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture\nFund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company (\"New Scilex Warrants\") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. (\"Sorrento\") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i)\nVickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture\nFund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants."}],"balance_after":99000,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":578160},"source":{"system":"sec-edgar","filing":"0001104659-22-119278","document":"tm2229408-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000110465922119278/tm2229408-1_4seq1.xml","form_type":"4"}},{"id":2115723,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":83028,"kind":"organization","name":"Vickers Venture Fund VI Pte Ltd","position":1,"cik":"0001839162","reported_name":"Vickers Venture Fund VI Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See footnote (1)"}},{"id":122360,"kind":"organization","name":"Vickers Venture Fund VI (Plan) Pte Ltd","position":2,"cik":"0001839160","reported_name":"Vickers Venture Fund VI (Plan) Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}},{"id":20713,"kind":"person","name":"Chi Jeffrey","position":3,"cik":"0001839163","reported_name":"Chi Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}},{"id":122361,"kind":"person","name":"Ho Chris","position":4,"cik":"0001838628","reported_name":"Ho Chris","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}}],"security":"Warrants","published_at":"2022-11-16T02:47:41.000Z","date":"2022-11-10","kind":"other","acquired":false,"shares":5261840,"ownership":{"direct":false,"nature":"By Vickers Venture Fund VI Pte Ltd"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I"},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company (\"New Scilex Warrants\") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. (\"Sorrento\") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i)\nVickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture\nFund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company (\"New Scilex Warrants\") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. (\"Sorrento\") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i)\nVickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture\nFund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants."}],"balance_after":901000,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":5261840},"source":{"system":"sec-edgar","filing":"0001104659-22-119278","document":"tm2229408-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000110465922119278/tm2229408-1_4seq1.xml","form_type":"4"}},{"id":2117023,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2022-11-15T18:38:57.000Z","date":"2022-11-10","kind":"other","acquired":true,"shares":307296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the assignment and transfer of the warrant to the Reporting Person by Vickers Venture Fund VI (Plan) Ltd (\"Sponsor Two\" and together with Sponsor One, the \"Sponsors\") pursuant the Warrant Transfer Agreement (as described below)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the warrant transfer agreement, dated as of October 12, 2022 (the \"Warrant Transfer Agreement\"), by and among the Reporting Person, the Sponsors, Vickers Vantage Corp. I (\"Vickers\") and Maxim Group LLC, Sponsor One transferred 2,796,704 warrant an aggregate of 3,104,000 warrants to the Reporting Person as over 90% of the public Vickers ordinary shares outstanding as of March 17, 2022 were redeemed in connection with the business combination as further described in Vickers' final prospectus and definitive proxy statement, dated October 28, 2022 (the \"Proxy Statement/Prospectus\") and filed with the Securities and Exchange Commission. The Warrant Transfer Agreement was entered into as consideration for the Reporting Person entering into a letter agreement with Scilex Holding Company (\"Scilex\") pursuant to which the Reporting Party would fund a loan to Scilex upon its request in the maximum aggregate amount of $10,000,000, as further described in the Proxy Statement/Prospectus."}],"balance_after":3104000,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":307296},"source":{"system":"sec-edgar","filing":"0000899243-22-035922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924322035922/doc4.xml","form_type":"4"}},{"id":2117022,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc.","position":1,"cik":"0000850261","reported_name":"Sorrento Therapeutics, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2022-11-15T18:38:57.000Z","date":"2022-11-10","kind":"other","acquired":true,"shares":2796704,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the assignment and transfer of the warrant to the Reporting Person by Vickers Venture Fund VI Pte Ltd (\"Sponsor One\") pursuant the Warrant Transfer Agreement (as described below)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the warrant transfer agreement, dated as of October 12, 2022 (the \"Warrant Transfer Agreement\"), by and among the Reporting Person, the Sponsors, Vickers Vantage Corp. I (\"Vickers\") and Maxim Group LLC, Sponsor One transferred 2,796,704 warrant an aggregate of 3,104,000 warrants to the Reporting Person as over 90% of the public Vickers ordinary shares outstanding as of March 17, 2022 were redeemed in connection with the business combination as further described in Vickers' final prospectus and definitive proxy statement, dated October 28, 2022 (the \"Proxy Statement/Prospectus\") and filed with the Securities and Exchange Commission. The Warrant Transfer Agreement was entered into as consideration for the Reporting Person entering into a letter agreement with Scilex Holding Company (\"Scilex\") pursuant to which the Reporting Party would fund a loan to Scilex upon its request in the maximum aggregate amount of $10,000,000, as further described in the Proxy Statement/Prospectus."}],"balance_after":2796704,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":2796704},"source":{"system":"sec-edgar","filing":"0000899243-22-035922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924322035922/doc4.xml","form_type":"4"}}]}